Gliclazide 60mg modified-release tablets
BNF presentation 0601021M0AAATAT within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0601021M0AAATAT
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
29,158
NHS spend (£)
£486,951.59
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 3,709 |
| February 2025 | 45 |
| December 2024 | 1,256 |
| November 2024 | 3,999 |
| October 2024 | 4,063 |
| September 2024 | 35 |
| August 2024 | 399 |
| July 2024 | 4,187 |
| May 2024 | 986 |
| July 2021 | 1,840 |
| June 2021 | 1,316 |
| December 2020 | 3,350 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 156 | No data available |
| Unknown pharmacy | 142 | No data available |
| Unknown pharmacy | 136 | No data available |
| Unknown pharmacy | 129 | No data available |
| Unknown pharmacy | 124 | No data available |
| Unknown pharmacy | 85 | No data available |
| Unknown pharmacy | 83 | No data available |
| Unknown pharmacy | 80 | No data available |
| Unknown pharmacy | 79 | No data available |
|
Sleaford Medical Group
ODS C83023
|
76 | 71E - LINCOLNSHIRE ICB |